Letters Chronic disease to top agenda

Beware tobacco companies’ spurious financial arguments

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1145 (Published 22 February 2011) Cite this as: BMJ 2011;342:d1145
  1. Constantine I Vardavas, visiting research scientist1,
  2. Panagiotis K Behrakis, president2,
  3. Gregory N Connolly, professor1
  1. 1Center for Global Tobacco Control, Harvard School of Public Health, Boston, MA 02215, USA
  2. 2European Network on Smoking and Tobacco Prevention (ENSP) and Harvard School of Public Health
  1. vardavas{at}hsph.harvard.edu

Despite the economic and health related gains of smoke-free legislation, those who oppose such legislation have suggested that it affects the revenue from the hospitality industry. Countries whose economies are under financial strain, such as Greece and Spain, are vulnerable to such pressure, …

View Full Text

Sign in

Log in through your institution

Subscribe